Glucagon-Like Peptide 1 and Type 1 Diabetes: NOD Ready for Prime Time?
Gespeichert in:
| Veröffentlicht in: | Endocrinology (Philadelphia) 2007-11, Vol.148 (11), p.5133-5135 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 5135 |
|---|---|
| container_issue | 11 |
| container_start_page | 5133 |
| container_title | Endocrinology (Philadelphia) |
| container_volume | 148 |
| creator | Hadjiyanni, Irene Drucker, Daniel J |
| description | |
| doi_str_mv | 10.1210/en.2007-1112 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3130593086</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1210/en.2007-1112</oup_id><sourcerecordid>3130593086</sourcerecordid><originalsourceid>FETCH-LOGICAL-c431t-653b2024d5d4369bc181c24f929a993ea69107a322312adab036bccc1021fb823</originalsourceid><addsrcrecordid>eNp1kMFLwzAUh4Mobk5vniXgwYudeUnaLl5ENjeF4YbMc0nTV-nc2pq0h_33trSwi17y8uDjez9-hFwDGwMH9oD5mDMWegDAT8gQlPS9EEJ2SoaMgfBCzsMBuXBu26xSSnFOBhAqyWASDMl8sauN_ipyb5l9I11jWWUJUqA6T-jmULbfWaZjrNA90vfVjH6gTg40LSxd22yPdNM8T5fkLNU7h1f9HJHP-ctm-uotV4u36fPSM1JA5QW-iDnjMvETKQIVG5iA4TJVXGmlBOpAAQu14FwA14mOmQhiYwwwDmk84WJEbjtvaYufGl0VbYva5s3JSIBgvhJsEjTUfUcZWzhnMY3KJqq2hwhY1JYWYR61pUVtaQ1-00vreI_JEe5baoC7Dijq8j-V16tER2KeFMZmOZYWnTum_DPAL-gtf-o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3130593086</pqid></control><display><type>article</type><title>Glucagon-Like Peptide 1 and Type 1 Diabetes: NOD Ready for Prime Time?</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Hadjiyanni, Irene ; Drucker, Daniel J</creator><creatorcontrib>Hadjiyanni, Irene ; Drucker, Daniel J</creatorcontrib><identifier>ISSN: 0013-7227</identifier><identifier>EISSN: 1945-7170</identifier><identifier>DOI: 10.1210/en.2007-1112</identifier><identifier>PMID: 17940186</identifier><language>eng</language><publisher>United States: Endocrine Society</publisher><subject>Animals ; Antibodies - therapeutic use ; CD3 Complex - immunology ; Combined Modality Therapy ; Diabetes mellitus (insulin dependent) ; Diabetes Mellitus, Type 1 - etiology ; Diabetes Mellitus, Type 1 - therapy ; Glucagon ; Glucagon-like peptide 1 ; Glucagon-Like Peptide 1 - physiology ; Glucagon-Like Peptide-1 Receptor ; Immunotherapy ; Mice ; Mice, Inbred NOD ; Models, Biological ; Peptides - therapeutic use ; Receptors, Glucagon - agonists ; Treatment Outcome ; Venoms - therapeutic use</subject><ispartof>Endocrinology (Philadelphia), 2007-11, Vol.148 (11), p.5133-5135</ispartof><rights>Copyright © 2007 by The Endocrine Society 2007</rights><rights>Copyright © 2007 by The Endocrine Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c431t-653b2024d5d4369bc181c24f929a993ea69107a322312adab036bccc1021fb823</citedby><cites>FETCH-LOGICAL-c431t-653b2024d5d4369bc181c24f929a993ea69107a322312adab036bccc1021fb823</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17940186$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hadjiyanni, Irene</creatorcontrib><creatorcontrib>Drucker, Daniel J</creatorcontrib><title>Glucagon-Like Peptide 1 and Type 1 Diabetes: NOD Ready for Prime Time?</title><title>Endocrinology (Philadelphia)</title><addtitle>Endocrinology</addtitle><subject>Animals</subject><subject>Antibodies - therapeutic use</subject><subject>CD3 Complex - immunology</subject><subject>Combined Modality Therapy</subject><subject>Diabetes mellitus (insulin dependent)</subject><subject>Diabetes Mellitus, Type 1 - etiology</subject><subject>Diabetes Mellitus, Type 1 - therapy</subject><subject>Glucagon</subject><subject>Glucagon-like peptide 1</subject><subject>Glucagon-Like Peptide 1 - physiology</subject><subject>Glucagon-Like Peptide-1 Receptor</subject><subject>Immunotherapy</subject><subject>Mice</subject><subject>Mice, Inbred NOD</subject><subject>Models, Biological</subject><subject>Peptides - therapeutic use</subject><subject>Receptors, Glucagon - agonists</subject><subject>Treatment Outcome</subject><subject>Venoms - therapeutic use</subject><issn>0013-7227</issn><issn>1945-7170</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMFLwzAUh4Mobk5vniXgwYudeUnaLl5ENjeF4YbMc0nTV-nc2pq0h_33trSwi17y8uDjez9-hFwDGwMH9oD5mDMWegDAT8gQlPS9EEJ2SoaMgfBCzsMBuXBu26xSSnFOBhAqyWASDMl8sauN_ipyb5l9I11jWWUJUqA6T-jmULbfWaZjrNA90vfVjH6gTg40LSxd22yPdNM8T5fkLNU7h1f9HJHP-ctm-uotV4u36fPSM1JA5QW-iDnjMvETKQIVG5iA4TJVXGmlBOpAAQu14FwA14mOmQhiYwwwDmk84WJEbjtvaYufGl0VbYva5s3JSIBgvhJsEjTUfUcZWzhnMY3KJqq2hwhY1JYWYR61pUVtaQ1-00vreI_JEe5baoC7Dijq8j-V16tER2KeFMZmOZYWnTum_DPAL-gtf-o</recordid><startdate>200711</startdate><enddate>200711</enddate><creator>Hadjiyanni, Irene</creator><creator>Drucker, Daniel J</creator><general>Endocrine Society</general><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope></search><sort><creationdate>200711</creationdate><title>Glucagon-Like Peptide 1 and Type 1 Diabetes: NOD Ready for Prime Time?</title><author>Hadjiyanni, Irene ; Drucker, Daniel J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c431t-653b2024d5d4369bc181c24f929a993ea69107a322312adab036bccc1021fb823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Animals</topic><topic>Antibodies - therapeutic use</topic><topic>CD3 Complex - immunology</topic><topic>Combined Modality Therapy</topic><topic>Diabetes mellitus (insulin dependent)</topic><topic>Diabetes Mellitus, Type 1 - etiology</topic><topic>Diabetes Mellitus, Type 1 - therapy</topic><topic>Glucagon</topic><topic>Glucagon-like peptide 1</topic><topic>Glucagon-Like Peptide 1 - physiology</topic><topic>Glucagon-Like Peptide-1 Receptor</topic><topic>Immunotherapy</topic><topic>Mice</topic><topic>Mice, Inbred NOD</topic><topic>Models, Biological</topic><topic>Peptides - therapeutic use</topic><topic>Receptors, Glucagon - agonists</topic><topic>Treatment Outcome</topic><topic>Venoms - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hadjiyanni, Irene</creatorcontrib><creatorcontrib>Drucker, Daniel J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Endocrinology (Philadelphia)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hadjiyanni, Irene</au><au>Drucker, Daniel J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glucagon-Like Peptide 1 and Type 1 Diabetes: NOD Ready for Prime Time?</atitle><jtitle>Endocrinology (Philadelphia)</jtitle><addtitle>Endocrinology</addtitle><date>2007-11</date><risdate>2007</risdate><volume>148</volume><issue>11</issue><spage>5133</spage><epage>5135</epage><pages>5133-5135</pages><issn>0013-7227</issn><eissn>1945-7170</eissn><cop>United States</cop><pub>Endocrine Society</pub><pmid>17940186</pmid><doi>10.1210/en.2007-1112</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0013-7227 |
| ispartof | Endocrinology (Philadelphia), 2007-11, Vol.148 (11), p.5133-5135 |
| issn | 0013-7227 1945-7170 |
| language | eng |
| recordid | cdi_proquest_journals_3130593086 |
| source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Animals Antibodies - therapeutic use CD3 Complex - immunology Combined Modality Therapy Diabetes mellitus (insulin dependent) Diabetes Mellitus, Type 1 - etiology Diabetes Mellitus, Type 1 - therapy Glucagon Glucagon-like peptide 1 Glucagon-Like Peptide 1 - physiology Glucagon-Like Peptide-1 Receptor Immunotherapy Mice Mice, Inbred NOD Models, Biological Peptides - therapeutic use Receptors, Glucagon - agonists Treatment Outcome Venoms - therapeutic use |
| title | Glucagon-Like Peptide 1 and Type 1 Diabetes: NOD Ready for Prime Time? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T18%3A43%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glucagon-Like%20Peptide%201%20and%20Type%201%20Diabetes:%20NOD%20Ready%20for%20Prime%20Time?&rft.jtitle=Endocrinology%20(Philadelphia)&rft.au=Hadjiyanni,%20Irene&rft.date=2007-11&rft.volume=148&rft.issue=11&rft.spage=5133&rft.epage=5135&rft.pages=5133-5135&rft.issn=0013-7227&rft.eissn=1945-7170&rft_id=info:doi/10.1210/en.2007-1112&rft_dat=%3Cproquest_cross%3E3130593086%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3130593086&rft_id=info:pmid/17940186&rft_oup_id=10.1210/en.2007-1112&rfr_iscdi=true |